Načítá se...
A Bayesian design for phase I cancer therapeutic vaccine trials
Phase I clinical trials are the first step in drug development to test a new drug or drug combination on humans. Typical designs of Phase I trials use toxicity as the primary endpoint and aim to find the maximum tolerable dosage. However, these designs are poorly applicable for the development of ca...
Uloženo v:
| Vydáno v: | Stat Med |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6399043/ https://ncbi.nlm.nih.gov/pubmed/30368868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.8021 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|